From the Department of Ophthalmology, Eye and ENT Hospital, Fudan University, Shanghai, China (Sun, Zhao, Zhang, Shen, Tian, Zhou); NHC Key Laboratory of Myopia, Fudan University, Shanghai, China (Sun, Zhao, Zhang, Shen, Tian, Zhou); Shanghai Research Center of Ophthalmology and Optometry, Shanghai, China (Sun, Zhao, Zhang, Shen, Tian, Zhou).
J Cataract Refract Surg. 2022 Feb 1;48(2):208-214. doi: 10.1097/j.jcrs.0000000000000733.
To evaluate the safety and efficacy of transepithelial accelerated corneal crosslinking (CXL) for advanced keratoconus eyes with maximum keratometry (Kmax) values >58 diopters (D).
Department of Ophthalmology, Eye and ENT Hospital, Fudan University, Shanghai, China.
Prospective parallel control study.
41 keratoconus eyes from 41 patients (mean age, 21.93 ± 5.48 years) who underwent transepithelial accelerated CXL were included prospectively. The enrolled eyes were divided into 2 groups according to their Kmax values (Group A, Kmax ≥58.0 D; Group B, Kmax <58.0 D). The examinations including assessment of uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), corneal topography, and corneal endothelial cell density count were conducted preoperatively, at 1 day, 1 month, 3 months, 6 months, and 1 year postoperatively.
All 41 eyes finished 1 year follow-up. No statistical difference was noted between the mean UDVA and CDVA in both groups throughout the follow-up duration. At 1-year postoperative follow-up, the CDVA increased by ≥2 lines in 45% (9/20) and 28.6% (6/21) eyes in Groups A and B, respectively. The mean preoperative Kmax in Groups A and B were 62.51 ± 3.34 D and 49.98 ± 4.32 D, respectively, and that at postoperative 1-year follow-up were 61.94 ± 4.11 D and 50.24 ± 4.72 D, respectively. The Kmax values of 30% (6/20) eyes in Group A and 4.8% (1/21) eyes in Group B decreased by more than 1 D. Deduction of flat K, steep K, mean K, and Kmax showed no significant difference between the 2 groups at 1-year postoperative follow-up. Moreover, 20% (4/20) and 23.8% (5/21) of eyes in Groups A and B, respectively, showed progress at postoperative 1-year follow-up.
Transepithelial accelerated CXL can safely treat advanced keratoconus eyes with Kmax values ≥58.0 D with some extent of efficacy and has similar progressive rate as Kmax values <58.0 D.
评估经上皮加速角膜交联(CXL)治疗最大角膜曲率(Kmax)值>58 屈光度(D)的晚期圆锥角膜眼的安全性和疗效。
复旦大学附属眼耳鼻喉科医院眼科,中国上海。
前瞻性平行对照研究。
前瞻性纳入 41 例(41 只眼)接受经上皮加速 CXL 的圆锥角膜患者,患者平均年龄 21.93±5.48 岁。根据 Kmax 值将纳入的眼分为 2 组(A 组,Kmax≥58.0 D;B 组,Kmax<58.0 D)。术前、术后 1 天、1 个月、3 个月、6 个月和 1 年分别进行未矫正距离视力(UDVA)、矫正距离视力(CDVA)、角膜地形图和角膜内皮细胞密度检查。
41 只眼均完成 1 年随访。2 组患者在整个随访期间的平均 UDVA 和 CDVA 均无统计学差异。术后 1 年随访时,A 组和 B 组分别有 45%(9/20)和 28.6%(6/21)的眼 CDVA 提高≥2 行。A 组和 B 组术前平均 Kmax 分别为 62.51±3.34 D 和 49.98±4.32 D,术后 1 年随访时分别为 61.94±4.11 D 和 50.24±4.72 D。A 组 30%(6/20)的眼 Kmax 值下降超过 1 D,B 组 4.8%(1/21)的眼 Kmax 值下降超过 1 D。术后 1 年随访时,2 组间扁平 K、陡峭 K、平均 K 和 Kmax 的降低无统计学差异。此外,A 组和 B 组分别有 20%(4/20)和 23.8%(5/21)的眼在术后 1 年随访时出现进展。
经上皮加速 CXL 可安全治疗 Kmax 值≥58.0 D 的晚期圆锥角膜眼,疗效有一定程度,其进展率与 Kmax 值<58.0 D 的眼相似。